Results 41 to 50 of about 65,339 (230)

Evaluation of a PACAP Peptide Analogue Labeled with (68)Ga Using Two Different Chelating Agents. [PDF]

, 2016
OBJECTIVE: The authors have conjugated chelating agents (DOTA and NODAGA) with a peptide (pituitary adenylate cyclase-activating peptide [PACAP] analogue) that has a high affinity for VPAC1 receptors expressed on cancer cells.
Chen, Chang-Po, Kumar, Pardeep, Mehta, Neil, Paudyal, Bishnuhari, Thakur, Mathew L., Tripathi, Sushil Kumar, Wickstrom, Eric   +6 more
core   +2 more sources

Excitation functions of proton induced nuclear reactions on natW up to 40 MeV [PDF]

, 2007
Excitation functions for the production of the 181,182m,182g,183,184g,186Re and 183,184Ta radionuclides from proton bombardment on natural tungsten were measured using the stacked-foil activation technique for the proton energies up to 40 MeV. A new data
Akkermans, Atkins, Atkins, Bishayee, Blann, Ceolin, Dmitriev, Dmitriev, Filoosofov, Gilbert, Gilmore, Guinyun Kim, Hauser, Hermanne, Johnson, Kairemo, Kalbach, Kalbach, Khalid, Khandaker, Kinsey, Koning, Kormali, Kwangsoo Kim, Kyung-Sook Kim, Lintschinger, Loska, Manwoo Lee, Mathias, Mayeen Uddin Khandaker, Nakamaru, Siegel, Tolmachev, Uddin, Wang, Weisskopf, Weisskopf, Young Seok Lee, Young-Ouk Lee, Young-Sik Cho, Zimmerman   +40 more
core   +2 more sources

RADIONUCLIDE IMAGING AND THERAPY OF NEUROENDOCRINE TUMOURS

Journal of Cancer and Allied Specialties, 2015
The incidence and prevalence of neuroendocrine tumours (NETs) are on the rise. Although NETs are a heterogeneous group of tumours, they have some similar properties, for example, that they can concentrate neuroamines and tend to have a high degree of ...
Shaunak Navalkissoor, Gopinath Gnanasegaran   +1 more
doaj   +1 more source

Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct 100Mo(p,2n) reaction [PDF]

, 2018
Evaluation of the radioisotopic purity of technetium-99m (99mTc) produced in GBq amounts by proton bombardment of enriched molibdenum-100 (100Mo) metallic targets at low proton energies (i.e. within 15\u201320 MeV) is conducted.
Bello, M., Boschi, A., Cicoria, G., De Nardo, L., Di Domenico, G., Duatti, A., Esposito, J., Groppi, F., Loriggiola, M., Manenti, S., Marengo, M., Martini, P., Melendez-Alafort, L., Mou, L., Pasquali, M., Pupillo, G., Rosato, A., Rossi-Alvarez, C., Salvini, A., Selva, A., Strada, L., Taibi, A., Uccelli, L., Uzunov, N. M., Zagni, F.   +24 more
core   +2 more sources

Copper radionuclides for theranostic applications: towards standardisation of their nuclear data. A mini-review

Frontiers in Chemistry, 2023
Copper has several clinically relevant radioisotopes and versatile coordination chemistry, allowing attachment of its radionuclides to biological molecules.
Mazhar Hussain, Mazhar Hussain, Syed M. Qaim, Ingo Spahn, M. Naveed Aslam, Bernd Neumaier   +5 more
doaj   +1 more source

Assessment of poststress left ventricular ejection fraction by gated SPECT: comparison with equilibrium radionuclide angiocardiography [PDF]

, 2010
PURPOSE: We compared left ventricular (LV) ejection fraction obtained by gated SPECT with that obtained by equilibrium radionuclide angiocardiography in a large cohort of patients.
ACAMPA, WANDA, Capasso E, Caprio MG, CUOCOLO, ALBERTO, De Luca S, Liuzzi R, Luongo L, Nicolai E, PETRETTA, MARIO   +8 more
core  

Appropriateness of referrals for single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in a developing community: A comparison between 2005 and 2009 versions of ACCF/ASNC appropriateness criteria [PDF]

, 2011
Appropriateness of referrals for myocardial perfusion imaging (MPI) in developing countries has not been extensively studied. Our study was conducted to describe the ordering practices of physicians and appropriateness of MPI referrals in Iran.
Alborzi, A., Gholamrezanezhad, A., Hassanpour, S., Mirpour, S., Mogharrabi, M., Ramezani, M., Rayatnavaz, M., Shirafkan, A.   +7 more
core   +1 more source

Potential application of lutetium-177-labeled prostate-specific membrane antigen-617 radioligand therapy for metastatic castration-resistant prostate cancer in a limited resource environment: Initial clinical experience after 2 years

World Journal of Nuclear Medicine, 2020
In recent years, lutetium-177 (177Lu)-labeled prostate-specific membrane antigen (PSMA)-617 has become a promising new therapeutic agent in patients with metastatic castration-resistant prostate cancer (mCRPC).
Majid Assadi, Samira Rezaei, Esmail Jafari, Seyed Javad Rekabpour, Mohammad Ravanbod, Farshad Zohrabi, AbdulLatif Amini, Saeid Keshmiri, Habibollah Dadgar, Hojjat Ahmadzadehfar   +9 more
doaj   +1 more source

Early Diagnosis of Alzheimer's disease by NIRF Spectroscopy and Nuclear Medicine [PDF]

, 2011
There is an urgent need for the early detection of diseases such as Alzheimer’s (AD) and Cancers in order to enable their successful treatment. Cancer is the second major cause of death after Heart Disease, and AD is the third major cause of death
I. C. Baianu
core   +1 more source

The application of radionuclide therapy for breast cancer

Frontiers in Nuclear Medicine
Radionuclide-mediated diagnosis and therapy have emerged as effective and low-risk approaches to treating breast cancer. Compared to traditional anatomic imaging techniques, diagnostic radionuclide-based molecular imaging systems exhibit much greater ...
Anna Musket, Anna Musket, Sandra Davern, Brianna M. Elam, Brianna M. Elam, Philip R. Musich, Jonathan P. Moorman, Jonathan P. Moorman, Yong Jiang, Yong Jiang   +9 more
doaj   +1 more source